ATE246192T1 - Ethyliden-derivate tricyclyscher carbapenems - Google Patents

Ethyliden-derivate tricyclyscher carbapenems

Info

Publication number: ATE246192T1
Authority: AT; Austria
Prior art keywords: formula; carbapenems; derivatives; disclosed; novel
Prior art date: 1996-12-18

Application number

AT97947251T

Other languages

English (en)

Inventor

Anton Copar

Tomaz Solmajer

Borut Anzic

Tadeja Kuzman

Tomaz Mesar

Darko Kocjan

Original Assignee

Lek Farmacevtska Druzba Dd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-18

Filing date

1997-12-18

Publication date

2003-08-15

1997-12-18 Application filed by Lek Farmacevtska Druzba Dd filed Critical Lek Farmacevtska Druzba Dd

2003-08-15 Application granted granted Critical

2003-08-15 Publication of ATE246192T1 publication Critical patent/ATE246192T1/de

Links

229940041011 carbapenems Drugs 0.000 title abstract 5
125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 abstract 4
208000035143 Bacterial infection Diseases 0.000 abstract 1
108090000204 Dipeptidase 1 Proteins 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
229940088710 antibiotic agent Drugs 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
239000003782 beta lactam antibiotic agent Substances 0.000 abstract 1
102000006635 beta-lactamase Human genes 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
239000002132 β-lactam antibiotic Substances 0.000 abstract 1
229940124586 β-lactam antibiotics Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

AT97947251T 1996-12-18 1997-12-18 Ethyliden-derivate tricyclyscher carbapenems ATE246192T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SI9600371A SI9600371B (sl)	1996-12-18	1996-12-18	Etilidenski derivati tricikličnih karbapenemov
PCT/SI1997/000035 WO1998027094A1 (en)	1996-12-18	1997-12-18	Ethylidene derivatives of tricyclic carbapenems

Publications (1)

Publication Number	Publication Date
ATE246192T1 true ATE246192T1 (de)	2003-08-15

Family

ID=20431974

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97947251T ATE246192T1 (de)	1996-12-18	1997-12-18	Ethyliden-derivate tricyclyscher carbapenems

Country Status (8)

Country	Link
US (1)	US6489318B1 (de)
EP (1)	EP0946558B1 (de)
JP (1)	JP4252628B2 (de)
AT (1)	ATE246192T1 (de)
AU (1)	AU5237598A (de)
DE (1)	DE69723864T2 (de)
SI (1)	SI9600371B (de)
WO (1)	WO1998027094A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2350907B (en) *	1999-06-09	2002-02-13	Keith Andrew Burton	Computer system
ECSP003699A (es)	1999-10-08	2002-04-23	Smithkline Beecham Corp	Inhibidores de fab i
DE60230934D1 (de)	2001-04-06	2009-03-05	Affinium Pharm Inc	Fab-i-inhibitoren
EP1575951B1 (de)	2002-12-06	2014-06-25	Debiopharm International SA	Heterozyclische verbindungen, verfahren zu deren herstellung und ihre verwendung als heilmittel
WO2004082586A2 (en) *	2003-03-17	2004-09-30	Affinium Pharmaceuticals, Inc.	Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
US8450307B2 (en)	2004-06-04	2013-05-28	Affinium Pharmaceuticals, Inc.	Therapeutic agents, and methods of making and using the same
US20090155316A1 (en) *	2004-12-13	2009-06-18	Apt Co., Ltd.	Oral Wash
EP2687533B1 (de)	2006-07-20	2017-07-19	Debiopharm International SA	Acrylamidderivate als FAB-I-Hemmer
EP1958630A1 (de) *	2007-02-13	2008-08-20	LEK Pharmaceuticals d.d.	Antibakterielle Kombination eines tricyclische Carbapenems und einem Antibiotikum
WO2008098374A1 (en)	2007-02-16	2008-08-21	Affinium Pharmaceuticals, Inc.	Salts, prodrugs and polymorphs of fab i inhibitors
EP2085084A1 (de)	2008-01-29	2009-08-05	LEK Pharmaceuticals D.D.	Verwendung eines Hemmers von Beta-Lactamasen und dessen Kombination mit Beta-Lactam-Antibiotika
EP2135871A1 (de) *	2008-06-18	2009-12-23	LEK Pharmaceuticals D.D.	Neuartige Trinemantibiotika und Hemmer von Beta-Lactamasen
KR101720885B1 (ko)	2012-06-19	2017-03-28	데비오팜 인터네셔날 에스 에이	(e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
RS61312B1 (sr)	2016-02-26	2021-02-26	Debiopharm Int Sa	Lek za lečenje infekcija dijabetskog stopala
LT3464336T (lt)	2016-06-01	2022-05-10	Athira Pharma, Inc.	Junginiai
MY203711A (en)	2019-02-14	2024-07-15	Debiopharm Int Sa	Afabicin formulation, method for making the same and uses thereof
JP7418475B2 (ja)	2019-06-14	2024-01-19	デバイオファームインターナショナルエス．エー．	バイオフィルムが関与する細菌感染症を治療するための医薬及びその使用
BR112022024729A2 (pt)	2020-06-05	2023-02-28	Kinnate Biopharma Inc	Inibidores de quinases do receptor do fator de crescimento de fibroblastos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0005349A1 (de) *	1978-05-06	1979-11-14	Beecham Group Plc	Alkylcarbapeneme, ihre Herstellung, pharmazeutische Zubereitungen und Zwischenprodukte
US4235922A (en) *	1979-06-15	1980-11-25	Merck & Co., Inc.	3-(2-Aminoethylthio)-6-ethyl-7-oxo-1-azabicyclo [3.2.0]hept-2-ene-2-carboxylic acid
AU636913B2 (en)	1989-10-11	1993-05-13	Takeda Chemical Industries Ltd.	Tricyclic carbapenem compounds
GB9104769D0 (en) *	1991-03-07	1991-04-17	Glaxo Spa	Heterocyclic compounds
GB9104832D0 (en) *	1991-03-07	1991-04-17	Glaxo Spa	Heterocyclic compounds
CA2065079C (en) *	1991-04-05	2003-03-18	Michiyuki Sendai	Polycyclic carbapenem compounds, their production and use
JPH06166688A (ja) *	1992-10-02	1994-06-14	Takeda Chem Ind Ltd	カルバペネム化合物、その製造法および抗菌組成物
GB9323137D0 (en) *	1993-11-10	1994-01-05	Glaxo Spa	Chemical compounds
GB9403729D0 (en) *	1994-02-26	1994-04-13	Glaxo Spa	Amine derivatives

1996
- 1996-12-18 SI SI9600371A patent/SI9600371B/sl not_active IP Right Cessation
1997
- 1997-12-18 US US09/319,660 patent/US6489318B1/en not_active Expired - Fee Related
- 1997-12-18 JP JP52763998A patent/JP4252628B2/ja not_active Expired - Fee Related
- 1997-12-18 EP EP97947251A patent/EP0946558B1/de not_active Expired - Lifetime
- 1997-12-18 DE DE69723864T patent/DE69723864T2/de not_active Expired - Lifetime
- 1997-12-18 AT AT97947251T patent/ATE246192T1/de active
- 1997-12-18 AU AU52375/98A patent/AU5237598A/en not_active Abandoned
- 1997-12-18 WO PCT/SI1997/000035 patent/WO1998027094A1/en not_active Ceased

Also Published As

Publication number	Publication date
US6489318B1 (en)	2002-12-03
AU5237598A (en)	1998-07-15
SI9600371A (sl)	1998-06-30
EP0946558B1 (de)	2003-07-30
JP4252628B2 (ja)	2009-04-08
DE69723864T2 (de)	2004-04-22
SI9600371B (sl)	2005-04-30
DE69723864D1 (en)	2003-09-04
JP2001506258A (ja)	2001-05-15
EP0946558A1 (de)	1999-10-06
WO1998027094A1 (en)	1998-06-25

Similar Documents

Publication	Publication Date	Title
DE69723864D1 (en)	2003-09-04	Ethyliden-derivate tricyclyscher carbapenems
ES2152485T3 (es)	2001-02-01	Procedimiento para preparar comprimidos que contienen amoxicilina y clavulanato recubiertos de una pelicula polimerica acuosa.
IL100100A0 (en)	1992-08-18	Novel hydroxamic acid and n-hydroxyurea derivatives and their use
GEP20002298B (en)	2000-11-25	Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
NZ510690A (en)	2002-10-25	Methods for administration of antibiotics
ES2160821T3 (es)	2001-11-16	Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
NO20002434L (no)	2000-05-11	Oksazolidinonderivater og farmasøytiske preparater
RU94030236A (ru)	1996-06-20	Производные 3 бета-алкенил-пенама, способ их получения, лекарственные средства и их применение для борьбы и предупреждения болезней
ATE211729T1 (de)	2002-01-15	Therapeutisch wirksame verbindungen
NO173736C (no)	1994-01-26	Analogifremgangsmaate for fremstilling av en terapeutisk aktiv forbindelse bestaaende hovedsaklig av diastereomer (I) av cefalosporinderivater
EP1227721A4 (de)	2004-09-22	Neue substituierte bernsteinsäure metall-beta-lactamase-inhibitoren und ihre verwendung zur behandlung von bakteriellen infektionen
BR9509889A (pt)	1997-12-30	Composto composição farmacêutica e processos para inibir beta-lactamases e para aumentar a atrividade biológica de um antibiótico do tipo beta-lactama
ATE161006T1 (de)	1997-12-15	Alkohole als kaliumchannelöffner und zur behandlung der harnincontinenz
MY104109A (en)	1993-12-31	Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
GR3004655T3 (de)	1993-04-28
BG101996A (en)	1998-11-30	9-n-ethylenederivatives of 9(s)-erythromycylamine
DK0675900T3 (da)	1998-03-09	Antibiotika GE 37468 A, B og C
MY101079A (en)	1991-07-16	Pharmaceutical formulation for the treatment of bacterial infections.
DE69429447D1 (de)	2002-01-24	Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
PT927722E (pt)	2003-07-31	Derivados beta beta-dissubstituidos de 9-desoxo-9a-n-etenil-9a-aza-9aza-9a-homoeritromicina
DE69429538D1 (de)	2002-01-31	Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
CA2100314A1 (en)	1995-01-13	Pharmaceutical Composition for the Treatment of Chronic Skin Ulcers
MX9708385A (es)	1998-01-31	Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.
MX9706759A (es)	1997-11-29	Uso de penciclovir para el tratamiento de virus deherpes 8 humano.

Legal Events

Date

Code

Title

Description

2004-03-15

UEP

Publication of translation of european patent specification

Ref document number: 0946558

Country of ref document: EP